The Robotic & Stereotactic Radiosurgery Programme is a ground-breaking project that Apollo Cancer Centres (ACC) and Accuray have introduced to the Indian subcontinent. This program, which will be implemented at ACC locations in Bengaluru and Chennai, marks a substantial advancement in the field of medical education and cancer treatment technology in India.
This initiative’s main objective is to train a wide spectrum of medical personnel, including radiation oncologists, physicists, radiation therapists, and technicians from India and the larger ASEAN region, in sophisticated robotic and stereotactic radiosurgery. The goal of this training program is to provide learners a thorough grasp of these cutting-edge technologies through in-depth talks, practical learning experiences, and hands-on demonstrations.
In the field of cancer care, where individualized and highly effective therapies are increasingly dependent on technical breakthroughs, the launch of such a program is especially necessary and essential. An important part of this effort is the CyberKnife S7TM System, a robotic radiation therapy system that is non-invasive and well-known for precisely treating tumors with the least amount of damage to surrounding healthy tissue. Its capacity to precisely administer large doses of radiation during a brief treatment duration represents a major breakthrough in cancer therapy.
The revolutionary effect of these technology on cancer care was highlighted by Apollo Hospital Enterprises’ President of Group Oncology and International, Dinesh Madhavan. He emphasized that programs such as the Robotic & Stereotactic Radiosurgery Programme improve training opportunities locally and give medical personnel the tools they need to effectively use CyberKnife technology.
The lead of Apollo Cancer Centre’s CyberKnife robotic radiosurgery program, Dr. Sridhar PS, emphasized the significance of this training program in improving oncologists’ abilities and expertise. Dr. Sridhar, who has extensive experience treating more than 5000 patients with the CyberKnife System, highlighted the program’s role in sharing important knowledge that will advance cancer treatment in the area.Accuray President and CEO Suzanne Winter emphasized the importance of the partnership in providing Apollo centers in India with increased access to cutting-edge cancer care technologies. She highlighted how the CyberKnife S7TM System can optimize patient results by empowering physicians to administer accurate, high-dose radiation treatments in fewer sessions, thus redefining treatment standards.
Apollo Cancer Centres’ Robotic & Stereotactic Radiosurgery Programme is a testament to their dedication to innovation and high standards in medical education. By providing top-notch training programs locally, ACC hopes to improve the abilities of medical professionals and establish new standards for cancer care throughout the subcontinent. This program is well-positioned to equip medical professionals with the skills and information required to deliver cutting-edge, minimally invasive care.
Furthermore, the program’s emphasis on all-encompassing education highlights Apollo’s commitment to developing India’s larger healthcare ecosystem. Apollo Cancer Centres hopes to develop a new generation of CyberKnife clinicians through the establishment of a strong educational center. These clinicians will progress the delivery of cancer care, which will help patients in the surrounding area.
SOURCE:
INDIA MED TODAY
